Ken Fisher's VRTX Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 25,218 shares of Vertex Pharmaceuticals Incorporated (VRTX) worth $11.43 M, representing 0.00% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in VRTX, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2019, adding 12,768 shares. Largest reduction occurred in Q1 2018, reducing 5,089 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Vertex Pharmaceuticals Incorporated (VRTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vertex Pharmaceuticals Incorporated (VRTX) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -741 | Reduce 2.85% | 25,218 | $453.36 |
| Q3 2025 | +204 | Add 0.79% | 25,959 | $391.65 |
| Q2 2025 | -4,914 | Reduce 16.02% | 25,755 | $445.20 |
| Q1 2025 | +761 | Add 2.54% | 30,669 | $484.83 |
| Q4 2024 | +2,886 | Add 10.68% | 29,908 | $402.71 |
| Q3 2024 | -1,083 | Reduce 3.85% | 27,022 | $465.09 |
| Q2 2024 | +582 | Add 2.11% | 28,105 | $468.72 |
| Q1 2024 | +843 | Add 3.16% | 27,523 | $418.01 |
| Q4 2023 | +334 | Add 1.27% | 26,680 | $406.90 |
| Q3 2023 | -3,105 | Reduce 10.54% | 26,346 | $347.75 |
| Q2 2023 | +2,018 | Add 7.36% | 29,451 | $351.92 |
| Q1 2023 | +1,364 | Add 5.23% | 27,433 | $315.08 |
| Q4 2022 | +486 | Add 1.90% | 26,069 | $288.77 |
| Q3 2022 | -670 | Reduce 2.55% | 25,583 | $289.53 |
| Q2 2022 | +1,669 | Add 6.79% | 26,253 | $281.80 |
| Q1 2022 | -687 | Reduce 2.72% | 24,584 | $260.98 |
| Q4 2021 | +1,157 | Add 4.80% | 25,271 | $219.62 |
| Q3 2021 | -899 | Reduce 3.59% | 24,114 | $181.39 |
| Q2 2021 | -1,040 | Reduce 3.99% | 25,013 | $201.62 |
| Q1 2021 | +1,226 | Add 4.94% | 26,053 | $214.91 |
| Q4 2020 | +353 | Add 1.44% | 24,827 | $236.36 |
| Q3 2020 | +1,151 | Add 4.94% | 24,474 | $272.13 |
| Q2 2020 | -428 | Reduce 1.80% | 23,323 | $290.31 |
| Q1 2020 | +1,398 | Add 6.25% | 23,751 | $237.97 |
| Q4 2019 | +228 | Add 1.03% | 22,353 | $218.94 |
| Q3 2019 | +276 | Add 1.26% | 22,125 | $169.40 |
| Q2 2019 | +6,660 | Add 43.85% | 21,849 | $183.40 |
| Q1 2019 | +12,768 | Add 527.39% | 15,189 | $183.95 |
| Q4 2018 | +223 | Add 10.15% | 2,421 | $165.63 |
| Q3 2018 | +2,198 | New Buy | 2,198 | $192.90 |
| Q1 2018 | -5,089 | Sold Out | 0 | $0.00 |
| Q4 2017 | +105 | Add 2.11% | 5,089 | $149.93 |
| Q3 2017 | -962 | Reduce 16.18% | 4,984 | $152.09 |
| Q2 2017 | +733 | Add 14.06% | 5,946 | $128.83 |
| Q1 2017 | +45 | Add 0.87% | 5,213 | $109.34 |
| Q3 2016 | +56 | Add 1.10% | 5,168 | $87.27 |
| Q2 2016 | -43 | Reduce 0.83% | 5,112 | $90.18 |
| Q1 2016 | -388 | Reduce 7.00% | 5,155 | $81.67 |
| Q4 2015 | +615 | Add 12.48% | 5,543 | $125.74 |
| Q3 2015 | +550 | Add 12.56% | 4,928 | $104.10 |
| Q2 2015 | -8 | Reduce 0.18% | 4,378 | $123.57 |
| Q1 2015 | +8 | Add 0.18% | 4,386 | $117.88 |
| Q4 2014 | -215 | Reduce 4.68% | 4,378 | $118.78 |
| Q3 2014 | -2,160 | Reduce 31.99% | 4,593 | $112.34 |
| Q2 2014 | +6,753 | New Buy | 6,753 | $94.62 |
Ken Fisher's Vertex Pharmaceuticals Incorporated Investment FAQs
Ken Fisher first purchased Vertex Pharmaceuticals Incorporated (VRTX) in Q2 2014, acquiring 6,753 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Vertex Pharmaceuticals Incorporated (VRTX) for 46 quarters since Q2 2014.
Ken Fisher's largest addition to Vertex Pharmaceuticals Incorporated (VRTX) was in Q1 2019, adding 15,189 shares worth $2.79 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 25,218 shares of Vertex Pharmaceuticals Incorporated (VRTX), valued at approximately $11.43 M.
As of the Q4 2025 filing, Vertex Pharmaceuticals Incorporated (VRTX) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Vertex Pharmaceuticals Incorporated (VRTX) was 30,669 shares, as reported at the end of Q1 2025.